A retrospective study on the prevalence of anti-phospholipid antibodies, thrombotic events and cutaneous signs of vasculopathy in 173 hospitalized COVID-19 patients

BACKGROUND: Hypercoagulability is a risk factor of thromboembolic events in COVID-19. Anti-phospholipid (aPL) antibodies have been hypothesized to be involved. Typical COVID-19 dermatological manifestations of livedo reticularis and digital ischemia may resemble cutaneous manifestations of anti-phos...

Descripción completa

Detalles Bibliográficos
Autores principales: Gasparini, Giulia, Canepa, Paola, Verdiani, Simonetta, Carmisciano, Luca, Cozzani, Emanuele, De Grazia, Denise, Andrea, Orsi, Icardi, Giancarlo, Parodi, Aurora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460963/
https://www.ncbi.nlm.nih.gov/pubmed/34541915
http://dx.doi.org/10.1177/20587384211042115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460963/
https://www.ncbi.nlm.nih.gov/pubmed/34541915
http://dx.doi.org/10.1177/20587384211042115

Ejemplares similares